Defective Heart Defibrillators recalled by Guidant Corporation

Written by Mike Mahon

On June17, 2005 Guidant Corporation recalled close to 50,000 heart defibrillators worldwide because of potential malfunctions that could cause injury or death. This recall comes inrepparttar wake of two recent deaths among patients who were implanted with Guidant defibrillators. It is believed that Guidant Corporation failed to inform doctors and patients thatrepparttar 148877 defibrillators contained a defect that could cause them to short-circuit.

The recalled Guidant defibrillators models include: ·Prizm 2 DR, Model 1861, manufactured on or before April 16, 2002 ·Contak Renewal, Model H135, manufactured on or before August 26, 2004 ·Contak Renewal 2, Model H155, manufactured on or before August 26, 2004 ·Prizm AVT Vitality SVT Renewal 3 ·AVT Renewal 4 AVT

On June 24, Guidant issued an advisory concerning these additional defibrillator devices: ·Contak Renewal 3 and 4 ·Renewal 3 and 4 AVT ·Renewal RF

Guidant admits that they discoveredrepparttar 148878 defect as early as 2002. However, even though they changedrepparttar 148879 manufacturing ofrepparttar 148880 devices, they continued to sellrepparttar 148881 defective defibrillators without notifyingrepparttar 148882 doctors or patients ofrepparttar 148883 defects.

Although Guidant has conducted this recall, they have not yet advised whether implanted defibrillators should be replaced. The Food and Drug Administration has advised patients to takerepparttar 148884 following steps: 1.Contact your doctor immediately to determine if your defibrillator is a model being recalled by Guidant. 2.Keep your regularly scheduled doctor appointments. 3.Contact your doctor immediately if you experience an electrical shock from your defibrillator. 4.Contact your doctor immediately if you notice a beeping sound coming from your defibrillator.

Zoloft Side Effects: Akathisia and Violent Behavior

Written by Margaret Wommack

Zoloft is an SSRI (selective serotonin reuptake inhibitor); a prescription drug that combats depression, anxiety, posttraumatic stress disorder (PTSD), panic disorder, obsessive-compulsive disorder (OCD), as well as other various problems. SSRIs work by allowing more serotonin to be released throughrepparttar brain. Seratonin is a brain chemical associated with happiness. Between nerve endings inrepparttar 148826 brain, there are synapses. All signals inrepparttar 148827 brain are transmitted through chemicals being produced then absorbed by one nerve and another. When these chemicals are released they are either taken in byrepparttar 148828 next nerve orrepparttar 148829 nerve that released them will re-absorb them andrepparttar 148830 signal doesn’t pass. Some antidepressants work by blockingrepparttar 148831 reuptake of Seratonin byrepparttar 148832 releasing nerve. That means that more Seratonin stays inrepparttar 148833 synapse inrepparttar 148834 hope that it will be absorbed byrepparttar 148835 new nerve which, inrepparttar 148836 case of Seratonin, would continuerepparttar 148837 signal of happiness.

Cont'd on page 2 ==> © 2005
Terms of Use